Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antineoplastic combinations containing HKI-272 and vinorelbine

Antineoplastic combinations containing HKI-272 and vinorelbine

US Patent 10111868 · Granted Oct 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antineoplastic combinations with mTOR inhibitor, trastuzumab and/or HKI-2722020
Antineoplastic combinations containing HKI-272 and vinorelbine2016
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2016
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine2014
Cut-point in PTEN protein expression that accurately identifies tumors and is pr2012